We are live on ! Find out more
CC

Cannell & Co Portfolio holdings

AUM $3.15B
1-Year Est. Return 30.62%
This Fund
S&P 500
This Quarter Est. Return
+8.79%
1 Year Est. Return
+30.62%
3 Year Est. Return
+51.59%
5 Year Est. Return
+187.25%
10 Year Est. Return
+311.51%
AUM
$2.82B
AUM Growth
+$180M
Cap. Flow
-$33.6M
Cap. Flow %
-1.19%
Top 10 Hldgs %
27.95%
Holding
252
New
10
Increased
83
Reduced
86
Closed
12

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$36.1M
2
CHTR icon
Charter Communications
CHTR
+$33.9M
3
LHX icon
L3Harris
LHX
+$20.4M
4
ABBV icon
AbbVie
ABBV
+$18.8M
5
RVTY icon
Revvity
RVTY
+$17.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$60.8M
2
TIF
Tiffany & Co.
TIF
+$55.9M
3
BHC icon
Bausch Health
BHC
+$29.3M
4
CLR
CONTINENTAL RESOURCES INC.
CLR
+$16M
5
NBLX
Noble Midstream Partners LP
NBLX
+$14.4M

Sector Composition

Rank Sector Weight
1 Technology 19.19%
2 Healthcare 18.54%
3 Industrials 12.76%
4 Financials 12.25%
5 Consumer Discretionary 11.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
YTEN
251
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
– –
-122
Closed -$59K
CELG
252
DELISTED
Celgene Corp
CELG
– –
-612,402
Closed -$60.8M
7 8 9 10
11

Similar funds

GW
GW & Wade Wellesley, Massachusetts $3.08B AUM 18.99% 1-Year Est. Return
PMEF
Point72 Middle East FZE Dubai, United Arab Emirates $3.38B AUM 14.09% 1-Year Est. Return
SS
Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return
BWM
Baystate Wealth Management Boston, Massachusetts $1.36B AUM 15.87% 1-Year Est. Return
DI
DFPG Investments Sandy, Utah $1.28B AUM 27.55% 1-Year Est. Return

Cannell & Co's Q4 2019 Portfolio in Review

As of Q4 2019, Cannell & Co held 252 positions worth $2.82B, up 6.8% from $2.64B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Cannell & Co's Q4 2019 filing shows 10 new, 83 increased, 86 reduced and 12 closed positions. Its largest new stake was Charter Communications: 73,678 shares worth $36.1M. The largest sale was Celgene Corp, an estimated $60.8M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Industrials.

  • Cannell & Co's largest Q4 2019 buy was Charter Communications: 73,678 shares worth $36.1M.
  • Cannell & Co added most to Bristol-Myers Squibb in Q4 2019, an estimated $36.1M increase.
  • Cannell & Co's biggest Q4 2019 reduction was Tiffany & Co., cutting an estimated $55.9M.
  • Cannell & Co fully exited Celgene Corp in Q4 2019, selling an estimated $60.8M.
  • Cannell & Co's ten largest holdings make up 28% of its $2.82B portfolio in Q4 2019.
  • Cannell & Co opened 10 new positions and closed 12 in Q4 2019.
  • Cannell & Co's portfolio value rose 6.8% quarter-over-quarter to $2.82B.

Based on Cannell & Co's 13F filing for Q4 2019, filed 10 Feb 2020.